Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.

Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jing Sun, Guibo Sun, Xiangbao Meng, Hongwei Wang, Yun Luo, Meng Qin, Bo Ma, Min Wang, Dayong Cai, Peng Guo, Xiaobo Sun
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science (PLoS) 2013-01-01
Edice:PLoS ONE
On-line přístup:http://europepmc.org/articles/PMC3665796?pdf=render
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky